ASN
ORPH

Advisory Services Network’s Orphazyme A/S ORPH Stock Holding History

Advisory Services Network’s Portfolio ORPH Stock Details ORPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50
Closed – – 3611
2021
Q2 		$0 Buy
+50
New +$403 ﹤0.01% 3689

Other funds holding ORPH

Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return
BAM
Blueshift Asset Management Red Bank, New Jersey $432M AUM 13.14% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisory Services Network's ORPH Position: Q3 2021 in Review

Advisory Services Network sold out of Orphazyme A/S (ORPH) in Q3 2021, closing a stake of 50 shares.

Advisory Services Network first reported a position in ORPH in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 22 funds tracked by Wall St. Rank hold ORPH as of Q3 2021.

  • Advisory Services Network reported no remaining Orphazyme A/S position as of Q3 2021 after selling out during the quarter.
  • Advisory Services Network sold 50 Orphazyme A/S shares in Q3 2021.
  • Advisory Services Network first reported a position in Orphazyme A/S in Q2 2021 and held it in 1 quarter.
  • Advisory Services Network's Orphazyme A/S position peaked at $0 in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Orphazyme A/S as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.